Symposia: Allogeneic Transplantation: Conditioning Regimens, Engraftment, and Acute Toxicities
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Combination therapy, Clinical trials, ALL, Lymphoid Leukemias, Clinical Practice (Health Services and Quality), Translational Research, Bone Marrow Failure Syndromes, Clinical Research, Thalassemia, Supportive Care, Pediatric, Hemoglobinopathies, Diversity, Equity, and Inclusion (DEI), Diseases, Immune Disorders, Immunodeficiency, Patient-reported outcomes, Treatment Considerations, Real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Research, Combination therapy, Clinical trials, ALL, Lymphoid Leukemias, Clinical Practice (Health Services and Quality), Translational Research, Bone Marrow Failure Syndromes, Clinical Research, Thalassemia, Supportive Care, Pediatric, Hemoglobinopathies, Diversity, Equity, and Inclusion (DEI), Diseases, Immune Disorders, Immunodeficiency, Patient-reported outcomes, Treatment Considerations, Real-world evidence, Lymphoid Malignancies, Myeloid Malignancies, Study Population, Human, Measurable Residual Disease
Saturday, December 7, 2024: 4:00 PM-5:30 PM
Room 6DE
(San Diego Convention Center)
Moderators:
Hisham Abdel Azim, MD, Loma Linda Cancer Center
and
Pashna N. Munshi, MD, H. Lee Moffitt Cancer Center
Disclosures:
No relevant conflicts of interest to declare.
This session will focus on strategies to improve transplant outcomes for pediatric-AYA patients through optimization of donor selection, preparative regimens and supportive care.
4:00 PM
4:15 PM
4:30 PM
4:45 PM
5:00 PM
5:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH